Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
The Mirror US on MSN7d
'We had to stop CPR on my 14-month-old - here's what triggered the difficult decision'A husband and wife team from Minnesota have opened up about the fateful decision they had to make about their 14-month-old ...
Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana ...
Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, today ...
Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...
Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] Dr Ma ...
Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.
Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.
News Medical on MSN6d
Evaluating the safety and efficacy of Tendvia mechanical thrombectomy for acute pulmonary embolismAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback